Cancer Care Portal | Latest News, Research, and Support

FDA Accepts Submitting of Ameluz for Superficial Basal Cell Carcinoma

From Medical Trials to CAR-T Cell Remedy: A Affected person’s Journey With Myeloma

How Caregivers Can Assist Liked Ones With Lung Most cancers Really feel in Management

Household Begins AYA Most cancers Basis After Lymphoma Prognosis

Childhood Most cancers Survivors Face Lengthy-Time period Meningioma Danger

The Cancer

Issues of the Coronary heart: Managing Cardiac Well being in Most cancers Survivorship

February 13, 2026

Belief Instincts When Looking for the Proper Most cancers Care Staff

February 13, 2026

Genomic Testing Guides Therapy for Affected person With Lung Most cancers

February 13, 2026

Mother with Stage 4 Lung Most cancers Highlights Biomarker Testing

February 12, 2026

Delving Into Dwelling Donation, Advocacy and Life After Liver Transplant

February 12, 2026

Editor - June 16, 2026

NCI’s Message and High Priorities

NCI’s Message and High Priorities

June 16, 2026

NCI’s Message and High Priorities

May 4, 2026

What Are Embolism Warning Indicators for Sufferers With Most cancers?

February 13, 2026

Proton Remedy Improves Survival in Sufferers With Decrease Grade Glioma

February 13, 2026

Issues of the Coronary heart: Managing Cardiac Well being in Most cancers Survivorship

February 13, 2026

Belief Instincts When Looking for the Proper Most cancers Care Staff

February 13, 2026

Don't Miss

NCI’s Message and High Priorities

NCI’s Message and High Priorities

What Are Embolism Warning Indicators for Sufferers With Most cancers?

Proton Remedy Improves Survival in Sufferers With Decrease Grade Glioma

Issues of the Coronary heart: Managing Cardiac Well being in Most cancers Survivorship

News

Professional Discusses FDA Approval of Chemo-Free Possibility for EGFR-Mutated Lung Most cancers

Editor - February 11, 2026

The FDA has accepted Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the primary and solely subcutaneous, chemo-free therapy for sufferers with EGFR-mutated non-small cell lung most...

News

FDA Clears Protocol Replace for Tasquinimod in Myelofibrosis Trial

Editor - February 11, 2026

Lively Biotech has obtained optimistic suggestions from regulators on a protocol modification to its ongoing proof-of-concept scientific trial evaluating tasquinimod in sufferers with myelofibrosis, a...

News

How Most cancers Stole My Peace of Thoughts and Taught Me Resilience

Editor - February 11, 2026

Being robbed is simply part of life.Once I was in grammar college, little girls and boys would copy off my exams, stealing my solutions to...

Vital Information

News

FDA Clears PD-L1 Check to Information Keytruda Use in Ovarian Most cancers

News

MRD Testing Could Supply Peace of Thoughts to Breast Most cancers Survivors

News

A Household’s Power Via Liver Most cancers and Residing Donation

News

Why Subcutaneous Darzalex Faspro Issues for Sufferers With A number of Myeloma

News

From Missed Indicators to Second Possibilities After a Liver Most cancers Prognosis

Editor - February 10, 2026

Keytruda Combo Accredited for Platinum-Resistant Ovarian Most cancers

Editor - February 10, 2026

Chris Draft Shares Steps to Assist Sufferers Regain Management After Most cancers

Editor - February 10, 2026

FDA Quick Observe Designation Highlights New Possibility in Superior Liver Most cancers

Editor - February 10, 2026

In search of a Dose of Hope Amidst Most cancers

Editor - February 10, 2026

FDA Clears Part 2b Research of Teverelix in Superior Prostate Most cancers

Editor - February 10, 2026

When Most cancers Care Turns into a Logistical Balancing Act

Facts

Research Hyperlinks Drug Remedy to Fewer Sizzling Flashes Throughout Prostate Most cancers Care

February 9, 2026

Why Breast Most cancers Care Is not One Measurement Matches All

February 9, 2026

Mother of 4 Shares Story of Her Breast Most cancers Prognosis

February 9, 2026

Most cancers Anniversaries Good and Unhealthy

February 9, 2026

A Liver Most cancers Journey Marked by Persistence, Household and Hope

February 9, 2026

FDA Grants Designation to Immunotherapy KB707 for Superior NSCLC

February 9, 2026

Latest Articles

News

Colon Most cancers: Prognosis, Staging and Therapy Throughout All Levels

Editor - January 3, 2026

Colon most cancers is a illness wherein cells within the lining of the colon develop uncontrollably, forming a tumor. The most typical...

News

Saying Goodbye to 2025 | CURE

Editor - January 2, 2026

It’s been an fascinating 12 months. Not a lot health-wise, fortunately, however well being issues are by no means removed from my...

News

FDA Approves Six New Most cancers Therapies in December 2025

Editor - January 2, 2026

The U.S. Meals and Drug Administration (FDA) accredited six new therapies in December 2025 for blood cancers, prostate most cancers, lung most...

News

Gastric Most cancers Care Evolves With Precision Oncology and New Therapies

Editor - January 2, 2026

Dr. Raghav Sundar defined in an interview with CURE how fast advances in precision oncology are reshaping look after sufferers with gastric...

News

Being Proactive about Breast Screening After Breast Most cancers

Editor - January 2, 2026

Within the close to yr, I'm happy with a decision I added to my well being guidelines after an annual screening mammogram....

1...383940...1,671 Page 39 of 1,671

Hot Topics

Understanding Your Stage 3 Clear Cell Renal Cell Carcinoma Prognosis

Hodgkin Lymphoma: What Ought to Newly Recognized Sufferers Know?

The Energy of Personalised Care in Breast Most cancers Therapy